Delivery Order SPE2D021DA002-SPE2D325F295U
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,878.00 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 8, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,575.60 for ENGERIX-B 20 mcg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 17, 2025, will be performed at the awardee's Park Ridge location. The contract was awarded without a set-aside designation, and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,969.50 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The delivery order covers ENGERIX-B 20 micrograms per milliliter in syringe format, a hepatitis B vaccine commonly administered to military personnel and federal healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,757.30 on July 15, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. The award, which carries an ultimate completion date of July 18, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain function. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe vaccines in 0.5 milliliter quantities. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,971.76 by the Defense Logistics Agency for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract utilizes firm fixed-price pricing with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025, with no set-aside designation applied. The place of performance is Park...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- This delivery order, valued at $2,175.12, awards DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, a contract for ENGERIX-B 20 MCG/ML vaccine syringes. The Defense Logistics Agency, a defense-focused component of the Department of Defense, funded this award on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will take place in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $37,832.55 firm fixed-price purchase order by the Department of Defense's Medical Supply Chain on August 10, 2025, with an ultimate completion date of August 25, 2025. The contract is designated as a Total Small Business set-aside and covers the supply of Meningococcal Group vaccines and related pharmaceutical products to support federal healthcare operations. The...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F295UDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,090.20 for ENGERIX-B 20 MCG/ML vaccine syringes. The award, issued on August 6, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain program, which procures pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026. The parent contract enables the agency to procure a comprehensive portfolio of pharmaceutical items, including prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables across multiple product categories. DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain reflects its consistent performance in providing direct distribution of medications and pharmacy services to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 8/6/25 |